• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: is aromatic N-oxide a structural alert for predicting DNA-reactive mutagenicity?为监管目的扩展定量构效关系(QSAR)以纳入专有知识:芳族N-氧化物是否是预测DNA反应性致突变性的结构警示?
Mutagenesis. 2019 Mar 6;34(1):67-82. doi: 10.1093/mutage/gey020.
2
Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicity.扩展定量构效关系以纳入用于监管目的的专有知识:以芳香胺致突变性为例的案例研究
Regul Toxicol Pharmacol. 2016 Jun;77:1-12. doi: 10.1016/j.yrtph.2016.02.003. Epub 2016 Feb 13.
3
Carbamates and ICH M7 classification: Making use of expert knowledge.氨基甲酸酯类与ICH M7分类:利用专家知识
Regul Toxicol Pharmacol. 2017 Jun;86:392-401. doi: 10.1016/j.yrtph.2017.03.025. Epub 2017 Apr 4.
4
Transitioning to composite bacterial mutagenicity models in ICH M7 (Q)SAR analyses.向 ICH M7(Q)SAR 分析中的组合细菌致突变性模型过渡。
Regul Toxicol Pharmacol. 2019 Dec;109:104488. doi: 10.1016/j.yrtph.2019.104488. Epub 2019 Oct 3.
5
A knowledge-based expert rule system for predicting mutagenicity (Ames test) of aromatic amines and azo compounds.一种基于知识的专家规则系统,用于预测芳香胺和偶氮化合物的致突变性(艾姆斯试验)。
Toxicology. 2016 Aug 31;370:20-30. doi: 10.1016/j.tox.2016.09.008. Epub 2016 Sep 16.
6
Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities.基于计算机系统和专家知识的潜在致突变杂质的结构评估。
Regul Toxicol Pharmacol. 2013 Oct;67(1):39-52. doi: 10.1016/j.yrtph.2013.05.001. Epub 2013 May 10.
7
Principles and procedures for implementation of ICH M7 recommended (Q)SAR analyses.国际人用药品注册技术协调会M7指导原则中推荐的(定量)构效关系分析的实施原则与程序
Regul Toxicol Pharmacol. 2016 Jun;77:13-24. doi: 10.1016/j.yrtph.2016.02.004. Epub 2016 Feb 11.
8
Mutagenic potential and structural alerts of phytotoxins.植物毒素的致突变潜力和结构警示。
Food Chem Toxicol. 2023 Mar;173:113562. doi: 10.1016/j.fct.2022.113562. Epub 2022 Dec 21.
9
Mutagenicity assessment strategy for pharmaceutical intermediates to aid limit setting for occupational exposure.用于辅助设定职业接触限值的药物中间体致突变性评估策略
Regul Toxicol Pharmacol. 2015 Nov;73(2):515-20. doi: 10.1016/j.yrtph.2015.10.001. Epub 2015 Oct 8.
10
Computing similarity between structural environments of mutagenicity alerts.计算诱变警示结构环境之间的相似性。
Mutagenesis. 2019 Mar 6;34(1):55-65. doi: 10.1093/mutage/gey032.

引用本文的文献

1
Novel (Q)SAR models for prediction of reversible and time-dependent inhibition of cytochrome P450 enzymes.用于预测细胞色素P450酶可逆性和时间依赖性抑制作用的新型(定量)构效关系模型
Front Pharmacol. 2025 Feb 12;15:1451164. doi: 10.3389/fphar.2024.1451164. eCollection 2024.
2
Structure-mutagenicity relationships on quinoline and indole analogues in the Ames test.艾姆斯试验中喹啉和吲哚类似物的结构-致突变性关系。
Genes Environ. 2024 Nov 14;46(1):23. doi: 10.1186/s41021-024-00316-6.
3
A scheme to evaluate structural alerts to predict toxicity - Assessing confidence by characterising uncertainties.一种评估结构警示以预测毒性的方案 - 通过描述不确定性来评估置信度。
Regul Toxicol Pharmacol. 2022 Nov;135:105249. doi: 10.1016/j.yrtph.2022.105249. Epub 2022 Aug 27.
4
Management of pharmaceutical ICH M7 (Q)SAR predictions - The impact of model updates.药品人用药品注册技术协调会国际协调会议(ICH)M7定量构效关系(QSAR)预测的管理——模型更新的影响
Regul Toxicol Pharmacol. 2020 Dec;118:104807. doi: 10.1016/j.yrtph.2020.104807. Epub 2020 Oct 13.

本文引用的文献

1
Mutagenic and carcinogenic structural alerts and their mechanisms of action.诱变和致癌结构警示及其作用机制。
Arh Hig Rada Toksikol. 2016 Sep 1;67(3):169-182. doi: 10.1515/aiht-2016-67-2801.
2
Validation of Computational Methods.计算方法的验证
Adv Exp Med Biol. 2016;856:165-187. doi: 10.1007/978-3-319-33826-2_6.
3
Quinoxaline 1,4-di-N-Oxides: Biological Activities and Mechanisms of Actions.喹喔啉 1,4-二氮氧化物:生物活性及作用机制
Front Pharmacol. 2016 Mar 21;7:64. doi: 10.3389/fphar.2016.00064. eCollection 2016.
4
Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicity.扩展定量构效关系以纳入用于监管目的的专有知识:以芳香胺致突变性为例的案例研究
Regul Toxicol Pharmacol. 2016 Jun;77:1-12. doi: 10.1016/j.yrtph.2016.02.003. Epub 2016 Feb 13.
5
Principles and procedures for implementation of ICH M7 recommended (Q)SAR analyses.国际人用药品注册技术协调会M7指导原则中推荐的(定量)构效关系分析的实施原则与程序
Regul Toxicol Pharmacol. 2016 Jun;77:13-24. doi: 10.1016/j.yrtph.2016.02.004. Epub 2016 Feb 11.
6
Updated recommended lists of genotoxic and non-genotoxic chemicals for assessment of the performance of new or improved genotoxicity tests.用于评估新的或改进的遗传毒性试验性能的遗传毒性和非遗传毒性化学品更新推荐清单。
Mutat Res Genet Toxicol Environ Mutagen. 2016 Jan 1;795:7-30. doi: 10.1016/j.mrgentox.2015.10.006. Epub 2015 Nov 4.
7
Establishing best practise in the application of expert review of mutagenicity under ICH M7.在国际人用药品注册技术协调会(ICH)M7指导原则下建立致突变性专家评审应用的最佳实践。
Regul Toxicol Pharmacol. 2015 Oct;73(1):367-77. doi: 10.1016/j.yrtph.2015.07.018. Epub 2015 Aug 4.
8
Heterocyclic N-Oxides - An Emerging Class of Therapeutic Agents.杂环氮氧化物——一类新兴的治疗药物。
Curr Med Chem. 2015;22(24):2819-57. doi: 10.2174/0929867322666150619104007.
9
(Q)SAR assessments of potentially mutagenic impurities: a regulatory perspective on the utility of expert knowledge and data submission.潜在诱变杂质的(定量)构效关系评估:关于专家知识和数据提交效用的监管视角
Regul Toxicol Pharmacol. 2015 Mar;71(2):295-300. doi: 10.1016/j.yrtph.2014.12.012. Epub 2014 Dec 26.
10
Applicability Domain ANalysis (ADAN): a robust method for assessing the reliability of drug property predictions.适用性域分析(ADAN):一种评估药物性质预测可靠性的稳健方法。
J Chem Inf Model. 2014 May 27;54(5):1500-11. doi: 10.1021/ci500172z. Epub 2014 May 13.

为监管目的扩展定量构效关系(QSAR)以纳入专有知识:芳族N-氧化物是否是预测DNA反应性致突变性的结构警示?

Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: is aromatic N-oxide a structural alert for predicting DNA-reactive mutagenicity?

作者信息

Amberg Alexander, Anger Lennart T, Bercu Joel, Bower David, Cross Kevin P, Custer Laura, Harvey James S, Hasselgren Catrin, Honma Masamitsu, Johnson Candice, Jolly Robert, Kenyon Michelle O, Kruhlak Naomi L, Leavitt Penny, Quigley Donald P, Miller Scott, Snodin David, Stavitskaya Lidiya, Teasdale Andrew, Trejo-Martin Alejandra, White Angela T, Wichard Joerg, Myatt Glenn J

机构信息

Sanofi, R&D Preclinical Safety Frankfurt, Industriepark Höchst, Frankfurt am Main, Germany.

Gilead Sciences, Nonclinical Safety and Pathobiology, Foster City, CA, USA.

出版信息

Mutagenesis. 2019 Mar 6;34(1):67-82. doi: 10.1093/mutage/gey020.

DOI:10.1093/mutage/gey020
PMID:30189015
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6402318/
Abstract

(Quantitative) structure-activity relationship or (Q)SAR predictions of DNA-reactive mutagenicity are important to support both the design of new chemicals and the assessment of impurities, degradants, metabolites, extractables and leachables, as well as existing chemicals. Aromatic N-oxides represent a class of compounds that are often considered alerting for mutagenicity yet the scientific rationale of this structural alert is not clear and has been questioned. Because aromatic N-oxide-containing compounds may be encountered as impurities, degradants and metabolites, it is important to accurately predict mutagenicity of this chemical class. This article analysed a series of publicly available aromatic N-oxide data in search of supporting information. The article also used a previously developed structure-activity relationship (SAR) fingerprint methodology where a series of aromatic N-oxide substructures was generated and matched against public and proprietary databases, including pharmaceutical data. An assessment of the number of mutagenic and non-mutagenic compounds matching each substructure across all sources was used to understand whether the general class or any specific subclasses appear to lead to mutagenicity. This analysis resulted in a downgrade of the general aromatic N-oxide alert. However, it was determined there were enough public and proprietary data to assign the quindioxin and related chemicals as well as benzo[c][1,2,5]oxadiazole 1-oxide subclasses as alerts. The overall results of this analysis were incorporated into Leadscope's expert-rule-based model to enhance its predictive accuracy.

摘要

(定量)构效关系或(Q)SAR对DNA反应性致突变性的预测对于支持新化学品的设计以及杂质、降解产物、代谢物、可提取物和浸出物以及现有化学品的评估都很重要。芳香族N-氧化物是一类常被认为具有致突变性警示作用的化合物,但其这种结构警示的科学原理尚不清楚且受到质疑。由于含芳香族N-氧化物的化合物可能以杂质、降解产物和代谢物的形式出现,准确预测这类化学品的致突变性很重要。本文分析了一系列公开可用的芳香族N-氧化物数据以寻找支持信息。本文还使用了先前开发的构效关系(SAR)指纹方法,生成了一系列芳香族N-氧化物子结构,并与包括药物数据在内的公共和专有数据库进行匹配。通过评估所有来源中与每个子结构匹配的致突变和非致突变化合物的数量,来了解该类别或任何特定子类是否似乎会导致致突变性。该分析导致对一般芳香族N-氧化物警示的降级。然而,确定有足够的公共和专有数据将醌二噁英及相关化学品以及苯并[c][1,2,5]恶二唑1-氧化物子类指定为警示。该分析的总体结果被纳入Leadscope基于专家规则的模型中,以提高其预测准确性。